Nipride Rtu

Active Ingredient(s): Sodium Nitroprusside
FDA Approved: * March 8, 2017
Pharm Company: * EXELA PHARMA SCIENCE
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Nipride Rtu Overview

Sodium nitroprusside (SNP), sold under the brand name Nitropress among others, is a medication used to lower blood pressure.[1] This may be done if the blood pressure is very high and resulting in symptoms, in certain types of heart failure, and during surgery to decrease bleeding.[1] It is used by continuous injection into a vein.[1] Onset is typically immediate and effects last for up to ten minutes.[1] Common side effects incl...

Read more Nipride Rtu Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_nitroprusside

Recent Nipride Rtu Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Nitroprusside
  • Injection: 25mg/ml, 50mg, 50mg/100ml, 50mg/vial
  • Solution: 10mg/50ml (0.2mg/ml), 20mg/100ml (0.2mg/ml), 50mg/100ml (0.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nipride Rtu: (3 results)

Sorted by National Drug Code
  • 51754-1006 Nipride Rtu 50 mg/ml Intravenous Solution, Concentrate by Exela Pharma Sciences, LLC
  • 51754-1018 Nipride Rtu .2 mg/ml Intravenous Injection, Solution by Exela Pharma Sciences, LLC
  • 51754-1029 Nipride Rtu .2 mg/ml Intravenous Injection, Solution by Exela Pharma Sciences, LLC

Other drugs which contain Sodium Nitroprusside or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 13 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA